Chinese researchers have applied for a national patent on an experimental Gilead Sciences Inc. drug that they believe might fight the novel coronavirus.
The Wuhan Institute of Virology -- based in the Chinese city at the center of the epidemic -- has applied for a patent in
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
